| Technical Name |
Glycan-maskingglycan-unmasking hemagglutinin antigens for universal influenza vaccine development |
| Project Operator |
National Tsing Hua University |
| Project Host |
吳夙欽 |
| Summary |
The invention provides a glycan-masking and/or glycan-unmasking hemagglutinin, wherein the glycosylation site(s) is added on globular headremoved on stem. The glycan-masking and/or glycan-unmasking hemagglutinin may induce neutralizing antibody against influenza virus,cross-reactive protection against different virus. The invention also provides a method for manufacturing these antigens.
|
| Scientific Breakthrough |
The invention provides a glycan-masking and/or glycan-unmasking hemagglutinin, wherein the glycosylation site(s) is added on globular headremoved on stem. The glycan-masking and/or glycan-unmasking hemagglutinin may induce neutralizing antibody against influenza virus,cross-reactive protection against different virus. The invention also provides a method for manufacturing these antigens.
|
| Industrial Applicability |
The market for seasonal influenza vaccines, sized at US$2.8 billion in 2008–2009 across the major markets, not including the potential of pandemic vaccines. The annual rate of influenza vaccine is approximately 12.6. Our invention provides a glycan-masking and/or glycan-unmasking hemagglutinin antigen design, which can be further used for developing “universal influenza vaccines\".
|
| Keyword |
influenza vaccine universal neutralizing antibody hemagglutinin glycan masking glycan unmasking globular head stem region antigen design vaccine design |
